SUMMARY
INTRODUCTION
Arthroscopic knee surgery is one of the most common surgeries performed in outpatient setting; however, postoperative pain is believed to be a major barrier for early discharge and rehabilitation (1) . Analgesics are commonly injected intraarticularly for analgesia after arthroscopic surgery, especially of knee joints (2, 3) . For the purpose of research, non-steroidal anti-inflammatory drugs and local anesthetics were used (4) (5) (6) (7) . Studies of intra-articular (i.a.) injections of these drugs are often associated l with pain modulations (7, 8) . On the other hand, the histopathological studies following i.a. administrations are a few in number and the aim of many experimental studies has been to investigate the activities of drugs in inflamed animal knees (9, 10) .
Dexmedetomidine, an imidazole compound, is the pharmacologically active dextroisomer of medetomidine that displays specific and selective a2-adrenoceptor agonism. The mechanism of action is unique and differs from those of currently used sedative agents, including clonidine. Although dexmedetomidine is approved for i.v., and i.m. use, no toxicological data exist regarding its i.a. administration. In this study we have investigated the effects of i.a. administration of dexmedetomidine in the rat knee joint.
MATERIALS and METHODS

Animals
The study was approved by the local ethics Committee on the Use of Live Animals in the Ministry of Health, Haydarpaşa Numune Training and Research Hospital. Fifty-one mature Sprague-Dawley rats weighing 250-300 g were included in the study. Power analysis showed that 33 and 18 subjects per study group were required.
Experimental procedure
Rats were divided into two groups. 33 rats were included in Group I and 18 rats in Group II. All rats were anesthesized by injection of 2 mg kg-¹ intraperitoneal ketamine hydrochloride.
In Group I rats, under aseptic conditions, 16.10-3 mol. litre -1 of dexmedetomidine (100 µg mL -1 2 mL of dexmedetomidine was diluted with 48 mL of physiological 0.9 % saline solution) was injected into the right, and 0.25 mL of physiological 0.9 % saline solution into the left. knee joints of the animals.The animals were then allowed to awake and returned to their cages. The rats were sacrificed by a lethal injection of ketamine hydrochloride at 24 th h (10 rats), at 48 th h (10 rats) and on the 7 th days (10 rats) after the drug administration. Three rats were sham operated; and sacrificed on the first, the second, and the seventh day after this procedure. In the second step, 100 µg ml -1 2 mL of dexmedetomidine was diluted with 3 mL of physiological 0.9 % saline solution (40 µg mL -1 ) and 16.10-2 mol. litre -1 of this diluted solution was administered intraarticularly into 6 rats. Each 2 mL vial contained 18 mg NaCl and sterile water for injection. A solution including 18 mg NaCI in 50 mL was prepared and 0.25 mL of this solution was administered into 6 rats. Besides, a solution containing 18 mg NaCI in 5 mL was prepared and 0.25 mL of this solution was administered into 6 rats. These rats were sacrificed on the 7 th day.
The knee joints were detached and examined for gross signs of hematoma. They were labeled accordingly (left/right, time of death, etc.), then placed in 10 % neutral buffered formaline for 4 weeks. The joints were then decalcified in 14 % EDTA for another 3 weeks , and then embedded in paraffin and processed for sectioning. Paraffin blocks were sectioned at 5 μm intervals and the prepared slides were stained with haematoxyline and eosin. Knee joints were excised, and a "blind" observer evaluated the slides for inflammation of the articular cartilage, inflammatory cell infiltration, hypertrophy, and hyperplasia of the synovial membrane.
Inflammatory changes in the joints were classified as follows:
1. No inflammation; 2. Minimal inflammation (mild congestion and edema); 3. Mild inflammation (congestion and edema, a few neutrophils); 4. Moderate inflammation (neutrophils and macrophages, synoviocytic hyperplasia); 5. Severe inflammation (neutrophils and macrophages, synoviocyte hyperplasia, fibrin exudation) (11) .
Statistical analysis
Statistical analysis was performed using a computer software package (Statistical Package for Social Sciences for Windows, 10.0). Data were tested for normality by examination of histograms and by the Kolmogorov-Smirnov test and reported accordingly as mean (±SD) or median (range). The Mann-Whitney U test was used to calculate the probability of the differences between the experimental and control groups at 24 h, 48 h, and 7 days being attributable to chance. A p<0.05 value was considered as significant.
RESULTS
There was no hematoma over the joint capsule on gross examination in control and dexmedetomidine groups. Histopathological findings in dexmedetomidine Group I were a regular synovial membrane at 24. hours (Figure 1 ), polymorphonuclear leucocytes, mast cells and a regular synovial membrane at 48. hours (Figure 2), mild polymorphonuclear leucocytes, lymphocytes and mild edema on the 7 th day. These findings were indicative of a moderate inflammation (Figure 3) . In Group II, scarce number of leucocytes, and lymphocytes along with plenty of mast cells, foci of microcalcifications due to localized trauma and increased number of leucocytes in the surrounding muscle tissue, thickening of synovial membrane and papillary proliferation on the 7 th day. Findings indicative of a moderate inflammation were also encountered on the 7 th with the 10-fold increase in concentration (Figure 4 ).
Histopathological changes were not determined in the rats which were administered a solution including 18 mg NaCI without dexmedetomidine. There were no histopathological changes in the saline-treated control joints. When the groups were compared for the degree inflammation, no significant differences for inflammatory changes were observed between the groups (p>0.05) ( Table 1 ). 
DISCUSSION
The aim of this study was to evaluate the effects of i.a. use of dexmedetomidine, which is a new, potent and selective alpha2 agonist effective on articular cartilage and synovial membrane. Arthroscopy of the knee joint is a common procedure that is routinely performed on an outpatient basis. Traditionally, oral analgesics are prescribed for the management of postoperative pain. The routine prescription of oral opioid analgesics administered on an as-needed basis, however, frequently results in inadequate pain relief. Unrelieved postoperative pain may delay discharge from the hospital, resulting in a prolonged hospital stay, inability to participate in rehabilitation programs, delayed recovery, poor outcome, and greater use of health care resources. At present, several techniques are available to treat pain following arthroscopic knee surgery; these include the use of opioids which provide either peripherally or centrally mediated analgesia, local anesthetics, nonsteroidal anti-inflammatory drugs, corticosteroids, and clonidine (12) (13) (14) (15) (16) (17) .
Recently, there is an increase trend in using anti-nociceptive drugs intra-articularly. However, pre-clinical or clinical studies performed to evaluate the local tissue toxicity of these drugs are not sufficient in number As questioned by Buerkle, Can the i.a. analgesics be used safely without performing pre-clinical studies? (18) . Dogan et al. (19) studied the changes in joint synovium and cartilage caused by i.a ketorolac and morphine. Macroscopic hematoma was observed in few rabbit joint capsules. In histopathological analysis, both groups revealed moderate cell hyperplasia or hypertrophy of synovial membrane, except ketorolac group on 24 th hour. Ketorolac is an non-steroid antiinflammatory drug (NSAID) approved only for intravenous use in USA. In this study, however, any toxic effect of its i.a. use was not observed and therefore, this route could be used safely. When studying the potential effects of Gadolinium (Gd)-DTPA-dimeglumine on synovial membrane and joint cartilage, since a minimal focal mononuclear cell infiltration wasobserved, its i.a. injection was considered safe (20) . Literature data showed that i.a. use of clonidine, which is another alpha2 agonist agent, has also been studied (21, 22) . Gentili et al., (23) stated that i.a. clonidine has a postoperative analgesic effect after knee arthroscopies, due its a peripheral mechanism of action.
Although there is no data in the literature on i.a. use of dexmedetomidine, it has been used as an adjuvant medication in regional anesthesia (24) . In our study, we have observed varying degrees of synovial membrane inflammatory cell infiltration and minimal or mild synovial membrane cell hyperplasia in the dexmedetomidine group. High-dose drug administration is as important as that of standard-dose in intra-articular drug administration. Suominen et al. (25) used i.a. bufexamac, which is another NSAID, in their study on horses. Moderate inflammation and effusion were observed only in the high-dose group. The glycosaminoglycan concentration of articular cartilage did not change. As a result, i.a. bufexamac was reported as a NSAID that could be used. In another study performed on rats, an increase in polymorphonuclear leukocyte level was observed four hours after administrating highdose i.a. capsaicin (pelargonic acid vallinylamide). Then, the number of mononuclear cells increased progressively. Therefore, high-dose capsaicin resulted in severe progressive inflammatory reaction (26) .
In another study Dogan et al. (27) demonstrated that when i.a. neostigmine and bupivacaine wereinjected in combination into the articular cartilage, a severe inflammation occurred. Same results are valid for local anesthetics, as well. As we know, i.a. local anesthetics are frequently used in the treatment of postoperative surgical pain. They are administered in high concentrations however, their neurotoxical and myotoxical effects can not be excluded. In a study of Pietruck, (28) lidocaine and bupivacaine have been found to have anti-inflammatory and analgesic properties in lower concentrations with a lesser degree of toxicity. Other i.a. drugs administered most frequently are the COX-2 inhibitors. Parecoxib alone has no effect on cartilage and synovium of normal rats' knees. It has shown inhibitory effects on the cartilage degeneration. In addition to its anti-inflammatory effects, it has been shown to inhibit excitatory amino acid release (29) . In other studies, all COX-2 inhibitors significantly reduced joint swelling. In conclusion, the selective inhibition of COX-2 may result in the amelioration of synovitis with a lowered risk of NSAID-induced cartilage damage in rheumatic disease (30) .
In our study, we administered two different concentrations of dexmedetomidine and found the same level of mild hyperplasia and hypertrophy of synovial membrane cells even if 10-fold concentrated drug was injected. The anticipated severe and progressive reaction against high dose dexmedetomidine has not occurred. Encountering with no histopathologic changes in the rats which received injections of a solution including 18 mg NaCI without dexmedetomidine demonstrated that the inflammation was a side effect of dexmedetomidine. However, the mild inflammation was observed after injection of 10-fold increased concentration of dexmedetomidine.
Many orthopedic approaches performed artroscopically cause moderate or severe pain. Therefore, a pain assessment and a pain treatment plan should be done. Although i.a. administration is a reliable method, its efficiency is controversial. The major reason for the controversy is the administration of such drugs without investigating their toxicological and pharmacokinetics effects in preclinical studies. Joint changes in rats may not, of course, be directly comparable to those found in humans. A direct comparison without human studies is not possible. However, Sprague-Dawley rats have often been used as a convenient animal model for toxicological studies.
Our results demonstrated that, a single i.a. injection of dexmedetomidine causes mild synovial inflammation. The effect is not dosedependent and can be induced by relatively small doses of dexmedetomidine. According to our results, we conclude that further research is needed on this topic.
